Home Cushing’s syndrome: hidden risk in usage of topical corticosteroids
Article
Licensed
Unlicensed Requires Authentication

Cushing’s syndrome: hidden risk in usage of topical corticosteroids

  • Ayşe Derya Buluş EMAIL logo , Nesibe Andıran and Mesut Koçak
Published/Copyright: May 22, 2014

Abstract

Iatrogenic Cushing’s syndrome in children may occur as a result of the application of exogenous steroids. Prolonged use of powerful corticosteroids suppresses adrenal functions and iatrogenic Cushing’s syndrome may develop particularly in infants who are given topical corticosteroids. We report here a case on three infants having Cushing’s syndrome with similar clinical presentations due to overuse of topical steroids for diaper dermatitis. The importance of exercising caution during the use of topical steroids is underlined in this study.


Corresponding author: Ayşe Derya Buluş, MD, Department of Pediatric Endocrinology, Kecioren Training and Research Hospital, Pinarbasi Mahallesi Sanatoryum Caddesi Ardahan sok. no:1 Kecioren 06310, Ankara, Turkey, Phone: +90 312 356 90 00, Fax: +90 312 356 90 22, E-mail:

References

1. Allen DB. Safety of inhaled corticosteroids in children. Pediatr Pulmonol 2002;33:208–20.10.1002/ppul.10040Search in Google Scholar

2. Hengge UR, Ruzicka T, Shwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006;54:1–15.10.1016/j.jaad.2005.01.010Search in Google Scholar

3. Wolkerstorfer A, Visser RL, De Waard van der Spek FB, Mulder PG, Oranje AP. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution. Br J Dermatol 2000;143:999–1004.10.1046/j.1365-2133.2000.03833.xSearch in Google Scholar

4. Şıklar Z, Bostancı I, Atli O, Dallar Y. An infantile Cushing syndrome due to misuse of topical steroid. Pediatr Dermatol 2004;21:561–3.10.1111/j.0736-8046.2004.21508.xSearch in Google Scholar

5. Andıran N. “Diaper Dermatit” ten Cushing Sendromuna. Yeni Tıp Dergisi 2007;24:112–4.Search in Google Scholar

6. Güven A, Gülümser O, Özgen T. Cushing’s syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse? J Pediatr Endocrinol Metab 2007;20:1173–82.10.1515/JPEM.2007.20.11.1173Search in Google Scholar

7. Semiz S, Yasemin BI, Ergin Ş, Candemir M, Polat A. Two cases of Cushing’s syndrome due to overuse of topical steroid in the diaper area. Pediatric Dermatol 2008;5:544–7.10.1111/j.1525-1470.2008.00735.xSearch in Google Scholar

8. Gilbertson EO, Spellman MC, Piacquadio DJ, Mulford MI. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998;38:318–21.10.1016/S0190-9622(98)70573-0Search in Google Scholar

9. Nield LS, Kamat D. Prevention, diagnosis and management of diaper dermatitis. Clin Pediatr 2007;6:480–6.Search in Google Scholar

10. Boumpas DT, Paliogianni F, Anastassiou ED. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol 1991;9:413–23.Search in Google Scholar

11. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing’s syndrome. Lancet 2001;357:783–91.10.1016/S0140-6736(00)04172-6Search in Google Scholar

12. Baş VN, Çetinkaya S, Aycan Z. Iatrogenic Cushing syndrome due to nasal steroid drops. Eur J Pediatr 2012;171:735–6.10.1007/s00431-011-1645-9Search in Google Scholar PubMed

13. Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Phys 2009;79:135–40.Search in Google Scholar

14. Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, et al. Low dose (1 μg) adrenocortocotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high dose (250 μg) test. Clin Endocrinol 2000;52:633–40.10.1046/j.1365-2265.2000.00984.xSearch in Google Scholar PubMed

15. Crowley S, Hindmarsh PC, Honour JW, Brook CGD. Reproducibility of the cortisol response to stimulation with a low dose of ACTH: the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol 1993;136:167–72.10.1677/joe.0.1360167Search in Google Scholar PubMed

16. Colao A, Pivanello R. The diagnosis of secondary adrenal insufficiency: low dose vs high dose ACTH stimulation test. J Endocrinol Invest 2003;26:1–2.10.1007/BF03345114Search in Google Scholar PubMed

Received: 2013-7-3
Accepted: 2014-4-1
Published Online: 2014-5-22
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Downloaded on 28.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0262/html?lang=en
Scroll to top button